More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

MEDLEMSNYHET - The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect ...

MEDLEMSNYHET - SignalChem Biotech (part of Sino Biological) offers integrated solutions to support kinase drug discovery, spanning target discovery to compound screening, profiling, and optimization.

Sjukdomars sällsynthet får nu ännu större betydelse när TLV ändrar sina arbetssätt. Förhoppningen är att tillgången till ...

Rådet består sedan innan av ordförande Sven-Eric Söder och ledamöterna Yasmine Bladelius (S), Åsa Gyberg-Karlsson (V), Per ...

Oskar Hansson, a professor of neurology at Lund University, will hold the title of Vice President for Neurodegenerative Disease Early Phase Clinical and Imaging Development at the American ...

Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.

The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release. – We are ...

Amerikanska Merck & Co, som i Europa är känt som MSD, har beslutat att avbryta utvecklingen av läkemedlen vibostolimab och favezelimab efter flera motgångar, enligt ett pressmeddelande. Dessa ...

The announcement came after a review that has been ongoing within the European Medicines Agency (EMA) since October last year, and means that its Committee for Medicinal Products for Human Use (CHMP) ...